ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World
ChromaDex’s research and development program reaches over 250 material transfer agreements (MTAs) on Niagen® and other ingredients, marking a milestone in NAD+ research LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) today celebrates over […]